Detalles de la búsqueda
1.
Improved survival of patients with primary plasma cell leukemia with VRd or daratumumab-based quadruplets: A multicenter study by the Greek myeloma study group.
Am J Hematol
; 98(5): 730-738, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36869876
2.
Real-world data on incidence, clinical characteristics and outcome of patients with macrofocal multiple myeloma (MFMM) in the era of novel therapies: A study of the Greco-Israeli collaborative myeloma working group.
Am J Hematol
; 95(5): 465-471, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32048329
3.
Tandem Autologous Stem Cell Transplantation Improves Outcomes in Newly Diagnosed Multiple Myeloma with Extramedullary Disease and High-Risk Cytogenetics: A Study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation.
Biol Blood Marrow Transplant
; 25(11): 2134-2142, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31288095
4.
Hypercalcemia remains an adverse prognostic factor for newly diagnosed multiple myeloma patients in the era of novel antimyeloma therapies.
Eur J Haematol
; 99(5): 409-414, 2017 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-28675766
5.
A prospective study of incidence, clinical and quality of life consequences of oral mucositis post palifermin prophylaxis in patients undergoing high-dose chemotherapy and autologous hematopoietic cell transplantation.
Ann Hematol
; 94(10): 1733-40, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26141369
6.
Lack of survival improvement with novel anti-myeloma agents for patients with multiple myeloma and central nervous system involvement: the Greek Myeloma Study Group experience.
Ann Hematol
; 94(12): 2033-42, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26420061
7.
The combination of lenalidomide and dexamethasone reduces bone resorption in responding patients with relapsed/refractory multiple myeloma but has no effect on bone formation: final results on 205 patients of the Greek myeloma study group.
Am J Hematol
; 89(1): 34-40, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-23983166
8.
Clinical features, outcome, and prognostic factors for survival and evolution to multiple myeloma of solitary plasmacytomas: a report of the Greek myeloma study group in 97 patients.
Am J Hematol
; 89(8): 803-8, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-24757085
9.
Re-evaluation of prognostic markers including staging, serum free light chains or their ratio and serum lactate dehydrogenase in multiple myeloma patients receiving novel agents.
Hematol Oncol
; 31(2): 96-102, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22961993
10.
The Chronic Kidney Disease Epidemiology Collaboration cystatin C (CKD-EPI-CysC) equation has an independent prognostic value for overall survival in newly diagnosed patients with symptomatic multiple myeloma; is it time to change from MDRD to CKD-EPI-CysC equations?
Eur J Haematol
; 91(4): 347-55, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-23829647
11.
Circulating angiopoietin-1 to angiopoietin-2 ratio is an independent prognostic factor for survival in newly diagnosed patients with multiple myeloma who received therapy with novel antimyeloma agents.
Int J Cancer
; 130(3): 735-42, 2012 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-21484787
12.
Elevated circulating sclerostin correlates with advanced disease features and abnormal bone remodeling in symptomatic myeloma: reduction post-bortezomib monotherapy.
Int J Cancer
; 131(6): 1466-71, 2012 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-22052418
13.
Autologous hematopoietic cell transplantation for relapsed multiple myeloma performed with cells procured after previous transplantation-study on behalf of CMWP of the EBMT.
Bone Marrow Transplant
; 57(4): 633-640, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35169284
14.
Real world data on the prognostic significance of monocytopenia in myelodysplastic syndrome.
Sci Rep
; 12(1): 17914, 2022 10 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-36289284
15.
Characteristics and outcome of multiple myeloma patients presenting with anaemia only: A retrospective multi-centre study.
Leuk Res
; 101: 106498, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33453475
16.
Pomalidomide Plus Low-Dose Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients: Results of the Real-World "POWERFUL" Study.
J Clin Med
; 10(7)2021 Apr 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33916376
17.
High serum lactate dehydrogenase adds prognostic value to the international myeloma staging system even in the era of novel agents.
Eur J Haematol
; 85(2): 114-9, 2010 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-20477863
18.
Lymphoma Severity and Type Are Associated With Aortic FDG Uptake by 18F-FDG PET/CT Imaging.
JACC CardioOncol
; 2(5): 758-770, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34396292
19.
Intercontinental study on pre-engraftment and post-engraftment Gram-negative rods bacteremia in hematopoietic stem cell transplantation patients: Risk factors and association with mortality.
J Infect
; 81(6): 882-894, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33186673
20.
Cystatin-C is an independent prognostic factor for survival in multiple myeloma and is reduced by bortezomib administration.
Haematologica
; 94(3): 372-9, 2009 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-19252175